Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactions
- 8 June 2010
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 51 (8) , 1414-1423
- https://doi.org/10.3109/10428194.2010.487622
Abstract
Herbal remedies are clearly a complementary and alternative modality used frequently by patients with hemato-oncological neoplasias during the course of their specific treatment. This review focuses on the potential safety and efficacy of herbs which are either used often or even on a daily basis by patients with hematological malignancies or indicated in the herbal pharmacopeias utilized by various traditional systems of medicine, in order to improve the well-being of patients with these cancers. Traditional medicine worldwide is a source for ongoing laboratory research related to the activity of herbs on cultured cell lines derived from patients with leukemia, lymphoma, and myeloma. Although the number of clinical studies in the field of hemato-oncology is limited, there appears to be potential efficacy in studies of mistletoe (Viscum album), green tea, Indian and Middle-Eastern spices, and some traditional Chinese, American, and European herbs. In addition to the potential efficacy of herbs, safety issues are also reviewed here, particularly, the documented and potential side effects, herb-drug interactions, and matters of quality control. Based on the above issues, the authors suggest enhancing doctor-patient communication regarding herbal use by adopting a patient-centered attitude based on scientific perspective.Keywords
This publication has 63 references indexed in Scilit:
- Complementary and alternative medicine use among long-term lymphoma survivors: A pilot studyAmerican Journal of Hematology, 2009
- Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2009
- Identification and Exploration of Herb-Drug Combinations Used By Cancer PatientsIntegrative Cancer Therapies, 2009
- A population-based, case–control study of green tea consumption and leukemia risk in southwestern TaiwanCancer Causes & Control, 2008
- Induction of maturation and activation of human dendritic cells: A mechanism underlying the beneficial effect of Viscum albumas complimentary therapy in cancerBMC Cancer, 2008
- The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosisBMC Cancer, 2008
- Curcumin Augments Gemcitabine Cytotoxic Effect on Pancreatic Adenocarcinoma Cell LinesCancer Investigation, 2007
- Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implicationsBlood, 2006
- Cytotoxic activities of Coriolus versicolor (Yunzhi) extract on human leukemia and lymphoma cells by induction of apoptosisLife Sciences, 2004
- Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 InhibitionClinical Pharmacokinetics, 2000